Drug Substance Analysis

Week of Sept. 20, 2010: Company and People Notes: DSM and PolyTherics in Development Deal; Kite Pharma Appoints President and CEO, And More.

September 23, 2010

ePT--the Electronic Newsletter of Pharmaceutical Technology

DSM and PolyTherics in Development Deal; Kite Pharma Appoints President and CEO, And More.

Week of Sept. 13, 2010: Company and People Notes: Genzyme Sells Genetics Business; Bausch and Lomb Names Vice-President; and More.

September 16, 2010

ePT--the Electronic Newsletter of Pharmaceutical Technology

Genzyme Sells Genetics Business; Bausch and Lomb Names Vice-President; and More.

Comply with ICH guidelines on impurities in new drug products!

September 03, 2010

The Agilent 2100 Bioanalyzer plus the Agilent High Sensitivity Protein 250 Kit automatically detects and quantifies protein impurities down to 0.05%  meeting ICH guideline Q3B(R2)!

Week of Aug. 30, 2010: Company and People Notes: Lonza Acquires Vivante; PPD Appoints VP of Quality Management; And More.

September 02, 2010

ePT--the Electronic Newsletter of Pharmaceutical Technology

Company and People Notes: Lonza Acquired Vivante; PPD Appoints VP of Quality Management; And More.

Week of Aug. 23, 2010: Company and People Notes: Quark and Novartis Form Agreement; Hospira CEO Retires; And More.

August 26, 2010

ePT--the Electronic Newsletter of Pharmaceutical Technology

Week of Aug. 23, 2010: Company and People Notes: Quark and Novartis Form Agreement; Hospira CEO Retires; And More.

Week of June 28, 2010: Company and People Notes: Pfizer Suspends Tanezumab Program; Actavis Appoints CEO; And More.

July 01, 2010

ePT--the Electronic Newsletter of Pharmaceutical Technology

Pfizer Suspends Tanezumab Program; Actavis Appoints CEO; And More.

Week of May 17, 2010: Company and People Notes: Lonza Acquires MODA; Sigma-Aldrich Exec to Retire; And More.

May 20, 2010

ePT--the Electronic Newsletter of Pharmaceutical Technology

Lonza Acquires MODA; Sigma-Aldrich Exec to Retire; And More.

IFPMA launches Ten Principles on Counterfeit Medicines

May 20, 2010

ePT--the Electronic Newsletter of Pharmaceutical Technology

The International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) published its "Ten Principles on Counterfeit Medicines" last week to draw public attention to the issue.

Week Of May 10, 2010: Company And People Notes: Ariad and Merck Restructure Collaboration; Genzyme Changes Leadership; and More

May 13, 2010

ePT--the Electronic Newsletter of Pharmaceutical Technology

Week Of May 10, 2010: Company And People Notes: Ariad and Merck Restructure Collaboration; Genzyme Changes Leadership; and More

Week Of May 3, 2010: Company And People Notes: FDA Approves AstraZeneca's and Pozen's Vimovo; Merck Announces Management Changes; And More.

May 06, 2010

ePT--the Electronic Newsletter of Pharmaceutical Technology

FDA Approves AstraZeneca's and Pozen's Vimovo; Merck Announces Management Changes; And More.